Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Biogen's (BIIB) Qalsody is the first therapy approved to treat a rare genetic form of ALS in Europe
Whether to use the 10-day, 21-day, 50-day and other moving averages, the question is, which one is best?